K

Kiniksa Pharmaceuticals Ltd
D

KNSA

27.870
USD
0.41
(1.49%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-116
حجم السوق
2,033,700,850
أصول ذات صلة
A
ASND
1.325
(0.77%)
174.320 USD
ICLR
ICLR
-0.832
(-0.55%)
150.070 USD
M
MCRB
0.550
(4.98%)
11.600 USD
M
MGNX
0.08000
(5.84%)
1.45000 USD
O
OMER
0.12000
(3.88%)
3.21000 USD
R
RDFN
0
(0.00%)
0 USD
S
SGMO
0.00200
(0.38%)
0.53200 USD
TEVA
TEVA
-0.045
(-0.26%)
17.010 USD
VRTX
VRTX
2.24
(0.49%)
459.27 USD
المزيد
الأخبار المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.